Senaparib in mCRPC Patients With Homologous Recombination Repair Gene Alterations After Docetaxel Treatment
Clinical trial NCT04822961 · UNKNOWN
Trial details
- NCT number
- NCT04822961
- Sponsor
- Impact Therapeutics, Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-31
- Primary completion
- 2024-05-01
- Enrollment
- 285
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.